Adialante

Pre-Seed
adialante.com Biotech & Healthcare San Francisco, United States 4 employees
Total Funding $500K
Latest Round Undisclosed Pre-Seed
Last Announced Jun 16, 2026
Investors 1 Backer
Decision Makers 2 Verified

About Adialante

Adialante develops low-cost, clinical-grade MRI systems and related services for accessible cancer and neuroimaging screening.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Pre-Seed
Global Headquarters San Francisco, United States
Team Size 4 employees
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website adialante.com
Domain Registered Date Nov 23, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Pre-Seed announced

  2. Milestone

    Website domain registered

    adialante.com

Investors & Backers

1
Y Combinator

Funding History

2 Rounds
Pre-Seed · Jun 16, 2026
Undisclosed
Venture Round · Undisclosed
$500,000 Source

Founders & Leadership

2

Efrain Torres

CEO & Co-Founder

Work email & phone locked Unlock →

Parker Jenkins

COO & Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts